CN102091042B - 一种单分散纳米微球药物载体的制备方法 - Google Patents
一种单分散纳米微球药物载体的制备方法 Download PDFInfo
- Publication number
- CN102091042B CN102091042B CN2011100086920A CN201110008692A CN102091042B CN 102091042 B CN102091042 B CN 102091042B CN 2011100086920 A CN2011100086920 A CN 2011100086920A CN 201110008692 A CN201110008692 A CN 201110008692A CN 102091042 B CN102091042 B CN 102091042B
- Authority
- CN
- China
- Prior art keywords
- monodisperse
- medicine carrier
- preparation
- nanosphere
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 239000002077 nanosphere Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000003756 stirring Methods 0.000 claims abstract description 20
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims abstract description 19
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 11
- 238000005119 centrifugation Methods 0.000 claims abstract description 10
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 10
- 239000012153 distilled water Substances 0.000 claims abstract description 8
- 239000005457 ice water Substances 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 17
- 208000035126 Facies Diseases 0.000 claims description 16
- 229930003427 Vitamin E Natural products 0.000 claims description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 15
- 229940046009 vitamin E Drugs 0.000 claims description 15
- 235000019165 vitamin E Nutrition 0.000 claims description 15
- 239000011709 vitamin E Substances 0.000 claims description 15
- -1 vitamin E succinic acid ester Chemical class 0.000 claims description 14
- 229940113116 polyethylene glycol 1000 Drugs 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 9
- 238000004220 aggregation Methods 0.000 claims description 7
- 230000002776 aggregation Effects 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 14
- 239000012071 phase Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- 239000012074 organic phase Substances 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000000599 controlled substance Substances 0.000 abstract 1
- 238000000464 low-speed centrifugation Methods 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 238000002604 ultrasonography Methods 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 description 19
- 239000003937 drug carrier Substances 0.000 description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100086920A CN102091042B (zh) | 2011-01-14 | 2011-01-14 | 一种单分散纳米微球药物载体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011100086920A CN102091042B (zh) | 2011-01-14 | 2011-01-14 | 一种单分散纳米微球药物载体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102091042A CN102091042A (zh) | 2011-06-15 |
CN102091042B true CN102091042B (zh) | 2013-01-09 |
Family
ID=44124423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011100086920A Active CN102091042B (zh) | 2011-01-14 | 2011-01-14 | 一种单分散纳米微球药物载体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102091042B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102728287B (zh) * | 2012-06-07 | 2014-12-10 | 东南大学 | 一种表面多孔的plga微球的制备方法 |
CN103933910B (zh) * | 2014-04-11 | 2016-01-20 | 浙江大学 | 聚合物多孔微球的制备方法 |
CN111973561B (zh) * | 2020-08-31 | 2022-06-07 | 常州药物研究所有限公司 | 去除聚合物微球溶剂中有机溶剂残留方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101697963A (zh) * | 2009-10-29 | 2010-04-28 | 福建医科大学附属协和医院 | 一种载多烯紫杉醇plga缓释微球的制备方法及其在超声介导下肿瘤间质化疗中的应用 |
-
2011
- 2011-01-14 CN CN2011100086920A patent/CN102091042B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101697963A (zh) * | 2009-10-29 | 2010-04-28 | 福建医科大学附属协和医院 | 一种载多烯紫杉醇plga缓释微球的制备方法及其在超声介导下肿瘤间质化疗中的应用 |
Non-Patent Citations (1)
Title |
---|
赵亮等.维生素E琥珀酸聚乙二醇酯在紫杉醇聚酸酐微球中的应用研究.《中国药师》.2007,第10卷(第5期),433-435. * |
Also Published As
Publication number | Publication date |
---|---|
CN102091042A (zh) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yang et al. | Nanosized sustained-release drug depots fabricated using modified tri-axial electrospinning | |
Dinarvand et al. | Effect of surfactant HLB and different formulation variables on the properties of poly-D, L-lactide microspheres of naltrexone prepared by double emulsion technique | |
Astete et al. | Synthesis and characterization of PLGA nanoparticles | |
Morikawa et al. | The use of an efficient microfluidic mixing system for generating stabilized polymeric nanoparticles for controlled drug release | |
JP6159787B2 (ja) | 治療用粒子の凍結乾燥に対する安定製剤 | |
Li et al. | Microencapsulation by solvent evaporation: State of the art for process engineering approaches | |
Ruan et al. | Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process | |
Liu et al. | Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method | |
Ueda et al. | Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation | |
Sun et al. | Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery | |
JP2017128565A (ja) | 初期過多放出が減少された高分子微小粒子の製造方法及びその方法により製造された高分子微小粒子 | |
JP5575667B2 (ja) | 薬物の投与のためのナノ粒子キャリア及びその製造方法 | |
CN101889985A (zh) | 一种载药纳米微球及其制备方法 | |
Ngwuluka et al. | Natural polymers in micro-and nanoencapsulation for therapeutic and diagnostic applications: part I: lipids and fabrication techniques | |
PT3010962T (pt) | Preparação de micropartículas polilactida-poliglicolida com um perfil de libertação sigmoide | |
EP2085080A1 (en) | Preparation of nanoparticles by using a vibrating nozzle device | |
CN102091042B (zh) | 一种单分散纳米微球药物载体的制备方法 | |
CN107714674A (zh) | 一种plga微球的制备方法 | |
Öztürk et al. | New approach to hypertension treatment: carvediol-loaded PLGA nanoparticles, preparation, in vitro characterization and gastrointestinal stability | |
Gonçalves et al. | Development of multicore hybrid particles for drug delivery through the precipitation of CO2 saturated emulsions | |
Levato et al. | Preparation of biodegradable polylactide microparticles via a biocompatible procedure | |
Sawalha et al. | Preparation of hollow polylactide microcapsules through premix membrane emulsification—effects of nonsolvent properties | |
CN103690491A (zh) | 一种peg-pla/pla复合载药纳米微球的制备方法 | |
Zhang et al. | An improvement of double emulsion technique for preparing bovine serum albumin-loaded PLGA microspheres | |
CN1973832B (zh) | 具有ct示踪效应的可生物降解纳米药物胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220207 Address after: 510098 room 3513, No. 372, Huanshi East Road, Yuexiu District, Guangzhou, Guangdong Patentee after: Guangzhou Zhikun Biotechnology Co.,Ltd. Address before: 510640 No. five, 381 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: SOUTH CHINA University OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231219 Address after: Room 3513, No. 372, Huanshi East Road, Yuexiu District, Guangzhou, Guangdong, 510030 Patentee after: Guangzhou Zhiyuan Biotechnology Co.,Ltd. Address before: 510098 room 3513, No. 372, Huanshi East Road, Yuexiu District, Guangzhou, Guangdong Patentee before: Guangzhou Zhikun Biotechnology Co.,Ltd. |